There is a broad variation in the risk of developing breast cancer among people who carry the BRCA1 and BRCA2 gene mutation, according to a new article. BRCA2 carrier status,” said lead author Colin Begg, PhD, Chair of the Department of Epidemiology and Biostatistics at Memorial Sloan-Kettering Cancer Center, “and the risks in carriers and their relatives must be influenced by other risk factors.”
